AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

143.190

-1.160-0.80%

Volume:1.50M

Turnover:215.56M

Market Cap:69.47B

PE:34.49

High:143.750

Open:141.900

Low:140.640

Close:144.350

52wk High:269.118

52wk Low:133.350

Shares:485.15M

Float Shares:483.95M

Volume Ratio:0.89

T/O Rate:0.31%

Dividend:4.24

Dividend Rate:2.96%

EPS(TTM):4.152

EPS(LYR):8.963

ROE:6.66%

ROA:6.58%

PB:2.56

PE(LYR):15.98

Loading ...

Overview Company News Filings

CSL Ltd - Working With Regulatory Authorities on Strategies to Ensure Stable Ongoing Supply for Hemgenix

THOMSON REUTERS

CSL Ltd - CSL Is Currently Experiencing a Temporary Global Stockout of Hemgenix

THOMSON REUTERS

3 ASX 200 shares at 52-week lows: Buy, hold, or sell?

Buy, hold, sell: BHP, CSL, and Woodside shares

ASX Midday Sector Update: Real Estate Stocks Advance, Health Care Stocks Struggle

MT Newswires Live

Australian shares: A once-in-a-decade chance to build wealth?

Should I invest $2,000 in the VAS ETF?

Should you buy CSL and Pro Medicus shares today?

Here are the latest growth forecasts for the CSL share price

3 ASX stocks brokers say could double in the next year

CSL (ASX:CSL) Valuation Check After A$1.5b Kankakee Expansion Commitment

Simply Wall St.

CitiFirst CSL SFIs Dividend Final Amount-CTW

Did CSL's US$1.5 Billion US Plasma Build-Out Just Shift CSL's (ASX:CSL) Investment Narrative?

Simply Wall St.

What on earth's going on with the CSL share price?

CSL Finance Board to Consider Debenture Issue

MT Newswires Live

CSL Shares Fall as It Enters Long-Term Agreement With Pan American Health Organization for Influenza Vaccines

MT Newswires Live

BRIEF-Csl Seqirus Signs Agreement With Pan American Health Organization

CSL Ltd - CSL Seqirus Will Supply Its Differentiated Influenza Vaccine Portfolio and, With Long-Term Partner Sinergium Biotech

THOMSON REUTERS

Australian Shares Rebound; Telix Says First Part of Phase Three Study Confirms Safety Profile of Drug Candidate

MT Newswires Live

Top 10 ASX 200 Stocks to Consider Following Market Downturn

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CSL.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":143.19,"timestamp":1774588320000,"preClose":144.35,"halted":0,"volume":1497215,"delay":0,"changeRate":-0.008036023553862117,"nameEN":"CSL LIMITED","floatShares":483950454,"shares":485151394,"eps":4.15158919233004,"marketStatus":"Market Closed","change":-1.16,"latestTime":"03-27 16:12:00 AEDT","open":141.9,"high":143.75,"low":140.64,"amount":215558404,"amplitude":0.021545,"askPrice":143.19,"askSize":1099,"bidPrice":142.7,"bidSize":500,"shortable":3,"etf":0,"ttmEps":4.15158919233004,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1774825200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":144.35,"dividendRate":0.028934,"openAndCloseTimeList":[[1774566000000,1774587600000]],"volumeRatio":0.8887150231169825,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":144.35,"auctionPrice":143.18,"auctionVolume":391551,"auction":3,"marketStatus":"盘后竞价","timestamp":1774588215609}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":483950454,"roa":"6.58%","roe":"6.66%","lyrEps":8.962811,"volumeRatio":0.8887150231169825,"shares":485151394,"dividePrice":4.24172,"high":143.75,"amplitude":0.021545,"preClose":144.35,"low":140.64,"week52Low":133.35,"pbRate":"2.56","psRate":"3.10","week52High":269.118,"institutionHeld":0,"latestPrice":143.19,"committee":-0.374609,"eps":4.15158919233004,"divideRate":0.029623,"volume":1497215,"delay":0,"ttmEps":4.15158919233004,"open":141.9,"prevYearClose":170.408,"prevWeekClose":138.5,"prevMonthClose":144.854,"prevQuarterClose":170.408,"fiveDayClose":138.5,"twentyDayClose":144.854,"sixtyDayClose":170.408,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":4,"dividendGrowthRate":0.11620984529927163,"fiveYearAvgDividendRate":0.013228653048611719},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"},{"date":"2025-08-19","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755561600000,"name":null,"time":"","dateTimestamp":1755525600000,"actualEps":null},{"date":"2025-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2025-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-09","payableDate":"2025-03-11","currency":"USD","dateTimestamp":1741525200000,"payDate":"2025-04-09"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620896479","title":"CSL Ltd - Working With Regulatory Authorities on Strategies to Ensure Stable Ongoing Supply for Hemgenix","url":"https://stock-news.laohu8.com/highlight/detail?id=2620896479","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620896479?lang=en_us&edition=fundamental","pubTime":"2026-03-17 23:46","pubTimestamp":1773762389,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nFWN4050QE:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","BK7501","BK7511","CSL.AU"],"gpt_icon":0},{"id":"2620479891","title":"CSL Ltd - CSL Is Currently Experiencing a Temporary Global Stockout of Hemgenix","url":"https://stock-news.laohu8.com/highlight/detail?id=2620479891","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620479891?lang=en_us&edition=fundamental","pubTime":"2026-03-17 23:46","pubTimestamp":1773762389,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nFWN4050QE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","BK7501","BK7511","CSL.AU"],"gpt_icon":0},{"id":"2620410150","title":"3 ASX 200 shares at 52-week lows: Buy, hold, or sell?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620410150","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620410150?lang=en_us&edition=fundamental","pubTime":"2026-03-17 12:54","pubTimestamp":1773723275,"startTime":"0","endTime":"0","summary":"S&P/ASX 200 Index shares are 0.32% higher as the market reacts positively to an 0.25% rise in interest rates. Meanwhile, several ASX 200 stocks hit new 52-week lows today.  Do they present a buying opportunity, or is it best to be cautious on these stocks?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/17/3-asx-200-shares-at-52-week-lows-buy-hold-or-sell-2/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/17/3-asx-200-shares-at-52-week-lows-buy-hold-or-sell-2/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["SEK.AU","BK7002","BK7503","XJO.AU","BK7511","CSL.AU","CAR.AU","BK7508","BK7501","BK7067"],"gpt_icon":0},{"id":"2620179884","title":"Buy, hold, sell: BHP, CSL, and Woodside shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620179884","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620179884?lang=en_us&edition=fundamental","pubTime":"2026-03-17 11:58","pubTimestamp":1773719902,"startTime":"0","endTime":"0","summary":"There are a lot of blue-chip ASX 200 shares to pick from on the Australian share market. But not all are necessarily buys right now. So, to narrow things down, let's see what analysts are saying about three of the most popular shares on the ASX 200 index. Here's what you need to know: Image source: Getty Images BHP Group Ltd  BHP is the world's largest mining company and a major producer of commodities such as iron ore, copper, and metallurgical coal. One positive currently working in its favour is the strength in copper prices. Copper is widely viewed as one of the most important commodities for electrification, renewable energy infrastructure, and electric vehicles. With demand expected to rise strongly over the coming decade, BHP's significant exposure to copper could become an increasingly valuable part of its portfolio. But does this make BHP shares a buy?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/17/buy-hold-sell-bhp-csl-and-woodside-shares-2/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/17/buy-hold-sell-bhp-csl-and-woodside-shares-2/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["WDS.AU","BK7507","CSL","SG9999004303.SGD","BK4168","BHP","BHP.AU","BK7511","LU1169589451.USD","BK7142","LU0300736492.USD","LU0300736062.USD","BK4585","BK7095","BK7067","LU1169590202.USD","SGXZ23171101.USD","CSL.AU","BK4588","LU0728928796.USD","BK7501","BK7508","BK4086"],"gpt_icon":0},{"id":"2620419424","title":"ASX Midday Sector Update: Real Estate Stocks Advance, Health Care Stocks Struggle","url":"https://stock-news.laohu8.com/highlight/detail?id=2620419424","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620419424?lang=en_us&edition=fundamental","pubTime":"2026-03-17 09:55","pubTimestamp":1773712554,"startTime":"0","endTime":"0","summary":"Real estate stocks advanced nearly 1% at midday Tuesday.Goodman Group (ASX:GMG) gained more than 1% in recent trade.On the flip side, the health care sector struggled, shedding almost 1%.CSL (ASX:CSL) shares were down nearly 1% in recent trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","BK4588","BK7099","BK7155","BK7508","BK7067","BK4585","BK7510","LABU","GMG.AU","XLV","XBI","BK7501","CSL.AU","BK7511"],"gpt_icon":0},{"id":"2620497799","title":"Australian shares: A once-in-a-decade chance to build wealth?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620497799","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620497799?lang=en_us&edition=fundamental","pubTime":"2026-03-17 06:30","pubTimestamp":1773700200,"startTime":"0","endTime":"0","summary":"At first glance, the Australian share market doesn't look particularly cheap.  Even after the recent pullback driven by escalating tensions in the Middle East, the S&P/ASX 200 Index (ASX: XJO) is stil","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/17/australian-shares-a-once-in-a-decade-chance-to-build-wealth/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/17/australian-shares-a-once-in-a-decade-chance-to-build-wealth/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["XJO.AU","BK7049","BK7511","TWE.AU","BK7070","BK7503","PME.AU","BK7067","TLX.AU","XRO.AU","CSL.AU","ALL.AU","BK7007","AMC.AU","TPW.AU","XKO.AU","BK7501","BK7508","WTC.AU","BK7063","BK7103","BK7044","SIG.AU","BK7078","BK7016","XAO.AU","FLT.AU","BK7107","COH.AU","BK7097","BK7505","JHX.AU","BK7094"],"gpt_icon":0},{"id":"2620948434","title":"Should I invest $2,000 in the VAS ETF?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620948434","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620948434?lang=en_us&edition=fundamental","pubTime":"2026-03-17 04:44","pubTimestamp":1773693863,"startTime":"0","endTime":"0","summary":"Exchange-traded funds  have become one of the simplest and most popular ways to invest in the share market. It's clear to see why this is the case. Instead of picking individual shares, investors can buy a single ETF and gain exposure to dozens or even hundreds of businesses at once. For investors looking for broad exposure to Australian shares, one of the most favoured options is the Vanguard Australian Shares Index ETF . So if I had $2,000 ready to invest, would I consider putting it into this ETF?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/17/should-i-invest-2000-in-the-vas-etf/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/17/should-i-invest-2000-in-the-vas-etf/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["CBA.AU","BK4550","BK7501","XAO.AU","BHP.AU","BK7016","BK7511","BK7503","TNE.AU","CSL.AU","BK7067","BK7507","BK4585","BK4588","VAS.AU","XJO.AU","XKO.AU","LOV.AU","BK7508","NWL.AU","BK7135","BK7128","BK7062","FDN","NAB.AU","BK7095"],"gpt_icon":0},{"id":"2620951954","title":"Should you buy CSL and Pro Medicus shares today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620951954","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620951954?lang=en_us&edition=fundamental","pubTime":"2026-03-17 03:00","pubTimestamp":1773687600,"startTime":"0","endTime":"0","summary":"Healthcare shares have been among the biggest fallers on the ASX over the past year. Two of the sector's biggest names — CSL Ltd  and Pro Medicus Ltd  — have both seen their share prices slump heavily. They declined roughly 40% or more over the past 12 months. When CSL and Pro Medicus shares fall this far, investors often start asking the same question: is this a buying opportunity, or a sign that more downside is ahead?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/17/should-you-buy-csl-and-pro-medicus-shares-today/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/17/should-you-buy-csl-and-pro-medicus-shares-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["CSL","CSL.AU","BK7501","LU0728928796.USD","SG9999004303.SGD","SGXZ23171101.USD","BK4086","BK7511","LU1169589451.USD","PME.AU","LU1169590202.USD","BK7094","BK7508","BK7067"],"gpt_icon":0},{"id":"2619485792","title":"Here are the latest growth forecasts for the CSL share price","url":"https://stock-news.laohu8.com/highlight/detail?id=2619485792","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619485792?lang=en_us&edition=fundamental","pubTime":"2026-03-16 06:00","pubTimestamp":1773612000,"startTime":"0","endTime":"0","summary":"The CSL Ltd (ASX: CSL) share price has been through a tough time over the past two years. As the chart below shows, it's down more than 50% since August 2024.  As a result of this decline, it has fall","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/16/here-are-the-latest-growth-forecasts-for-the-csl-share-price-4/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/16/here-are-the-latest-growth-forecasts-for-the-csl-share-price-4/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["SGXZ23171101.USD","BK7501","IE0034235071.USD","LU1863844749.USD","BK4588","BK4086","BK7067","LU1169589451.USD","BK7041","LU1169590202.USD","BK7153","MQG.AU","BK4118","BK7508","BK4534","BK7046","WES.AU","BK4585","LU0728928796.USD","SG9999004303.SGD","LU3187612489.SGD","LU1829250122.USD","CSL","CSL.AU","LU1863844665.USD","UBS","BK7511"],"gpt_icon":0},{"id":"2619483450","title":"3 ASX stocks brokers say could double in the next year","url":"https://stock-news.laohu8.com/highlight/detail?id=2619483450","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619483450?lang=en_us&edition=fundamental","pubTime":"2026-03-16 04:30","pubTimestamp":1773606600,"startTime":"0","endTime":"0","summary":"With March bringing significant volatility for ASX stocks, there is plenty of opportunity for value investors. Unsurprisingly, much of the opportunity lies with ASX healthcare and technology stocks th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/16/3-asx-stocks-brokers-say-could-double-in-the-next-year/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/16/3-asx-stocks-brokers-say-could-double-in-the-next-year/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["CSL.AU","BK7501","PME.AU","BK7511","XJO.AU","BK7016","BK7067","WTC.AU","BK7094","BK7503","BK7508"],"gpt_icon":0},{"id":"2619144761","title":"CSL (ASX:CSL) Valuation Check After A$1.5b Kankakee Expansion Commitment","url":"https://stock-news.laohu8.com/highlight/detail?id=2619144761","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619144761?lang=en_us&edition=fundamental","pubTime":"2026-03-14 08:41","pubTimestamp":1773448890,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) has just committed A$1.5b to expand its Kankakee, Illinois manufacturing site, using its Horizon 2 process to lift plasma therapy output and add hundreds of U.S. jobs.\nSee our latest analysis for CSL.\nDespite committing fresh capital to grow its U.S. footprint, CSL’s share price has faced pressure, with a 30 day share price return decline of 13.71% and a 1 year total shareholder return loss of 42.19%, suggesting recent news is being weighed against longer term concerns.\nIf CSL’s...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-valuation-check-after-a15b-kankakee-expansion-com","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-valuation-check-after-a15b-kankakee-expansion-com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","LU1169590202.USD","BK7511","BK4086","LU0728928796.USD","CSL","BK7508","SG9999004303.SGD","LU1169589451.USD","SGXZ23171101.USD","CSL.AU","BK7501"],"gpt_icon":0},{"id":"2619567761","title":"CitiFirst CSL SFIs Dividend Final Amount-CTW","url":"https://stock-news.laohu8.com/highlight/detail?id=2619567761","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619567761?lang=en_us&edition=fundamental","pubTime":"2026-03-13 08:58","pubTimestamp":1773363498,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260313:nASX4y5CS9","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nASX7KzSnD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7511","BK7508","CSL.AU","BK7501"],"gpt_icon":0},{"id":"2619540831","title":"Did CSL's US$1.5 Billion US Plasma Build-Out Just Shift CSL's (ASX:CSL) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2619540831","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619540831?lang=en_us&edition=fundamental","pubTime":"2026-03-13 05:31","pubTimestamp":1773351079,"startTime":"0","endTime":"0","summary":"CSL has recently broken ground on a US$1.50 billion expansion of its Kankakee, Illinois plasma-therapy manufacturing facility, adding at least 300 new pharmaceutical jobs and incorporating its patented Horizon 2 process to increase immunoglobulin and albumin production capacity by 2031.\nThis large-scale build-out not only deepens CSL’s U.S. manufacturing footprint but also advances its goal of end-to-end plasma processing within the United States, which may be important for supply resilience...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/did-csls-us15-billion-us-plasma-build-out-just-shift-csls-as","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/did-csls-us15-billion-us-plasma-build-out-just-shift-csls-as","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","CSL.AU","BGSX","BK4086","LU1169590202.USD","SGXZ23171101.USD","LU0728928796.USD","BK7511","SG9999004303.SGD","LU1169589451.USD","CSL","BK7508","BK7501"],"gpt_icon":0},{"id":"2619808156","title":"What on earth's going on with the CSL share price?","url":"https://stock-news.laohu8.com/highlight/detail?id=2619808156","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619808156?lang=en_us&edition=fundamental","pubTime":"2026-03-12 05:45","pubTimestamp":1773265500,"startTime":"0","endTime":"0","summary":"It has been a rough year for shareholders of CSL Ltd . Earlier this week, the biotech giant's share price hit a multi-year low of $140.93 during a broader market selloff. Even after a modest rebound, the stock is still trading at $142.58, which leaves it down roughly 43% over the past 12 months. For a company long considered one of the highest-quality businesses on the ASX, that sort of decline naturally raises questions. What exactly has gone wrong, and does the weakness create an opportunity for investors?This is where I think the debate becomes interesting. According to analysts at Morgans, CSL's first-half result was \"softer and less clean than expected,\" with profit declining and impairments wei","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/12/what-on-earths-going-on-with-the-csl-share-price/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/12/what-on-earths-going-on-with-the-csl-share-price/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7508","CSL.AU","LU1169590202.USD","BK4086","SGXZ23171101.USD","LU1169589451.USD","BK7067","BK7501","LU0728928796.USD","SG9999004303.SGD","BK7511","CSL"],"gpt_icon":0},{"id":"2618947105","title":"CSL Finance Board to Consider Debenture Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2618947105","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618947105?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:50","pubTimestamp":1773233409,"startTime":"0","endTime":"0","summary":"CSL Finance (NSE:CSLFINANCE, BOM:530067) said its board will meet on March 18 to consider fund raising through issue of non-convertible debentures on a private placement basis, according to a Wednesday filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7511","BK7501","BK4086","SG9999004303.SGD","LU0728928796.USD","BK7508","SGXZ23171101.USD","LU1169590202.USD","LU1169589451.USD","CSL","CSL.AU","BK7067"],"gpt_icon":0},{"id":"2618956579","title":"CSL Shares Fall as It Enters Long-Term Agreement With Pan American Health Organization for Influenza Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2618956579","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618956579?lang=en_us&edition=fundamental","pubTime":"2026-03-11 09:15","pubTimestamp":1773191753,"startTime":"0","endTime":"0","summary":"CSL  shares were down nearly 2% in recent trading on Wednesday after it said in a late Tuesday statement that CSL Seqirus entered into a long-term agreement with the Pan American Health Organization Regional Revolving Fund to advance influenza protection in the Latin America region.CSL Seqirus will supply its differentiated portfolio of influenza vaccines, working with its long-term production partner, the Argentina-based Sinergium Biotech, to localize vaccine filling and distribution.CSL Seqirus and Sinergium will invest $10 million to enable the transfer of technology capability, which will add to the recent $25 million investment by Sinergium Biotech to increase local filling capacity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4117","BK7511","BK7501","SGXZ23171101.USD","LU0728928796.USD","BK4107","CSL","SG9999004303.SGD","BK7508","CSL.AU","LU1169589451.USD","AFG","BK7067","BK4086","LU1169590202.USD"],"gpt_icon":1},{"id":"2618050951","title":"BRIEF-Csl Seqirus Signs Agreement With Pan American Health Organization","url":"https://stock-news.laohu8.com/highlight/detail?id=2618050951","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618050951?lang=en_us&edition=fundamental","pubTime":"2026-03-10 23:04","pubTimestamp":1773155040,"startTime":"0","endTime":"0","summary":"BRIEF-Csl Seqirus Signs Agreement With Pan American Health OrganizationMarch 10  - CSL Ltd CSL.AX:CSL SEQIRUS SIGNS LONG-TERM AGREEMENT WITH PAN AMERICAN HEALTH ORGANIZATIONCSL SEQIRUS WILL SUPPLY ITS DIFFERENTIATED INFLUENZA VACCINE PORTFOLIO AND, WITH LONG-TERM PARTNER SINERGIUM BIOTECHFurther company coverage: CSL.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY1FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7501","BK7511","CSL.AU","BK7067"],"gpt_icon":0},{"id":"2618951729","title":"CSL Ltd - CSL Seqirus Will Supply Its Differentiated Influenza Vaccine Portfolio and, With Long-Term Partner Sinergium Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2618951729","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618951729?lang=en_us&edition=fundamental","pubTime":"2026-03-10 23:00","pubTimestamp":1773154827,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY1FH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","CSL.AU","BK7501","BK7067"],"gpt_icon":0},{"id":"2618198572","title":"Australian Shares Rebound; Telix Says First Part of Phase Three Study Confirms Safety Profile of Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2618198572","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618198572?lang=en_us&edition=fundamental","pubTime":"2026-03-10 13:50","pubTimestamp":1773121856,"startTime":"0","endTime":"0","summary":"Australian shares rebounded at Tuesday's close as market sentiment improved over US President Donald Trump's comments on the conflict in the Middle East.The S&P/ASX 200 Index regained 1.09%, or 93.60 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ORI.AU","BK7067","CSL.AU","XKO.AU","TLX.AU","EBIT","BK7511","XJO.AU","XAO.AU","BK7501","BK7508","BK7017"],"gpt_icon":0},{"id":"1157525084","title":"Top 10 ASX 200 Stocks to Consider Following Market Downturn","url":"https://stock-news.laohu8.com/highlight/detail?id=1157525084","media":"Trading Random","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157525084?lang=en_us&edition=fundamental","pubTime":"2026-03-10 10:14","pubTimestamp":1773108866,"startTime":"0","endTime":"0","summary":"The ASX 200 index experienced a significant decline on Monday, driven by a sharp increase in oil prices amid escalating tensions in the Middle East.While such market corrections can be concerning in...","market":null,"thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Top 10 ASX 200 Stocks to Consider Following Market Downturn","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4077","LU2008162690.USD","GMG.AU","BK7155","BK4585","BK7067","BK7099","BK4504","IE00B5TLWC47.USD","BK7094","BK4082","BK7007","BK7508","LU2177674079.SGD","PME.AU","RMD.AU","BK7016","BK7510","WTC.AU","BK7002","TNE.AU","LU0170899867.USD","BK7503","BK4167","BK7511","LNW.AU","BK4548","BK4567","COH.AU","BK7501","XRO.AU","BK7078","REA.AU","CSL.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":198,"code":"91000000","status":"200"}]}}